HIV 1 Infection Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
D
Not yet recruiting
- Hypertension
- +3 more
- (no location specified)
2022-04-05
Apr 5, 2022U
Not yet recruiting
- Resilience
- +2 more
- RISE+
- Stress Reduction Control
- (no location specified)
2022-03-29
Mar 29, 2022J
Withdrawn
- Pregnancy
- HIV-1-infection
- Standard dose Truvada®
- Pregnancy-adjusted dose Truvada®
- (no location specified)
2022-03-28
Mar 28, 2022S
Completed
- HIV-1-infection
- PENNVAX-GP
- +3 more
- Los Angeles, California
- +1 more
2022-04-04
Apr 4, 2022P
Recruiting
- HIV-1-infection
- Liuzhou, Guangxi, China
- +2 more
2022-03-31
Mar 31, 2022U
Completed
- HIV-1-infection
- Hypovitaminosis D
- 25-Hydroxyvitamin D
- Lahore, Punjab/ lahore/Pakistan, Pakistan
- +1 more
2022-03-31
Mar 31, 2022J
Active, not recruiting
- HIV-1-infection
- Mobile-enhanced Engagement Intervention
- Baltimore, MarylandCenter for Adolescent and Young Adult Health at Johns Hopkins Ha
2022-03-29
Mar 29, 2022U
Active, not recruiting
- HIV-1-infection
- Saline
- +2 more
- Salt Lake City, Utah
- +7 more
2022-03-30
Mar 30, 2022U
Enrolling by invitation
- HIV-1-infection
- Integrating PrEP delivery
- Kampala, UgandaInfectious Diseases Institute, Makerere University
2022-03-28
Mar 28, 2022W
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- +2 more
- 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Saline Placebo
- São Paulo, Brazil
- +2 more
2022-03-25
Mar 25, 2022E
Recruiting
- HIV-1-infection
- EBT-101
- San Francisco, California
- +2 more
2022-03-24
Mar 24, 2022M
Completed
- HIV-1-infection
- abacavir, dolutegravir and lamivudine dispersible tablets
- Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
- Montréal, Quebec, CanadaAltasciences
2022-03-10
Mar 10, 2022U
Recruiting
- HIV-1-infection
- Methamphetamine-dependence
- Oral Methamphetamine
- Placebo oral capsule
- San Francisco, CaliforniaSan Francisco General Hospital
2022-03-22
Mar 22, 2022U
Recruiting
- HIV-1-infection
- +2 more
- Home visit delivery strategy
- Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
2022-03-07
Mar 7, 2022G
T
Not yet recruiting
- HIV-1-infection
- (no location specified)
2022-03-15
Mar 15, 2022D
Active, not recruiting
- HIV-1-infection
- 10E8.4/iMab
- Orlando, Florida
- +1 more
2022-02-28
Feb 28, 2022S
Recruiting
- HIV-1-infection
- Clinical management informed by HIV-1 genotypic resistance testing
- Seboche, Butha-Buthe, Lesotho
- +6 more
2022-02-21
Feb 21, 2022G
Active, not recruiting
- HIV-1-infection
- B/F/TAF
- Haifa, Israel
- +4 more
2022-03-08
Mar 8, 2022C
Active, not recruiting
- HIV-1-infection
- PRO 140 350
- +2 more
- San Francisco, CaliforniaQuest Clinical Research
2022-03-04
Mar 4, 2022E
Enrolling by invitation
- HIV-1-infection
- EBT-101
- San Francisco, California
- +2 more
2022-03-04
Mar 4, 2022S
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
- Shanghai, Shanghai, China
- +2 more
2022-03-01
Mar 1, 2022G
Active, not recruiting
- HIV-1-infection
- Long Beach, California
- +11 more
2022-02-24
Feb 24, 2022A
Recruiting
- HIV-1-infection
- Port-au-Prince, Bicentaire, Haiti
- +13 more
2022-02-22
Feb 22, 2022A
Not yet recruiting
- HIV-1-infection
- Etonogestrel (ENG) Subdermal Implants
- (no location specified)
2022-02-22
Feb 22, 2022